about
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administ...
Read More
1.10
0.07
(6.80%)
23,316
XNAS Volume
XNAS 10 Aug, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Immuron Ltd (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..